Is vitamin C an effective antihypertensive supplement? A review and analysis of the literature.
OBJECTIVE
Hypertension is a common condition with high mortality from associated diseases. Epidemiological evidence suggests that a dietary deficiency of vitamin C may be a risk factor for hypertension. However the literature on vitamin C interventional trials appears divided on the efficacy of vitamin C utilization clinically.


METHODS
A literature search and review of published trials using vitamin C in treating patients with hypertension was undertaken. Relevant references were located using MEDLINE (1966-2005) and the bibliographies of located articles.


RESULTS
Thirteen trials making up 14 separate groups were identified and analyzed providing a pooled population of 284 hypertensive patients (52% female), with a weighted mean age of 58.8 +/- 9.5 years. Median vitamin C dose and study intervention duration was 500mg/day and 6 weeks respectively. The weighted mean baseline and post treatment systolic blood pressures across all 14 groups were 149.6 +/- 11.1 and 145.7 +/- 11.0 mmHg respectively. This represented a systolic blood pressure decrease of 3.9 mmHg. Seven of the 14 groups ascertained statistically significant reductions (p < .05) in systolic blood pressures. However only 2 of the 14 groups found significant reductions in diastolic blood pressure. The weighted mean baseline and post treatment diastolic blood pressures across all 14 groups were 84.6 +/- 4.4 and 82.5 +/- 4.1 mmHg respectively. This represented a diastolic blood pressure decrease of 2.1 mmHg.


CONCLUSIONS
Vitamin C supplementation in hypertensive patients appears to possess modest effects on reducing systolic blood and diastolic blood pressure.
McRae
Marc P
MP
National University of Health Sciences, Department of Physiology and Biochemistry, Lombard, IL.
Lancet. 2000 Apr 8;355(9211):1271-2; author reply 1273-4
10770322
J Okla State Med Assoc. 1984 Jun;77(6):177-82
6737106
Int J Vitam Nutr Res Suppl. 1989;30:95-102
2507711
Diabet Med. 1994 Nov;11(9):893-8
7705029
Ann N Y Acad Sci. 1992 Sep 30;669:205-13; discussion 213-4
1444026
Clin Sci (Lond). 1997 Apr;92(4):361-5
9176034
J Cardiovasc Pharmacol. 2001 Mar;37(3):333-8
11243424
Isr Med Assoc J. 2004 Dec;6(12):742-6
15609886
J Biol Chem. 1993 Jan 15;268(2):1304-9
8419332
Am J Hypertens. 2000 May;13(5 Pt 1):564-7
10826412
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6377-81
2762330
Hypertension. 2000 Apr;35(4):936-41
10775565
J Hum Hypertens. 1993 Aug;7(4):403-5
8410936
Am J Clin Nutr. 1993 Feb;57(2):213-7
8424391
Int J Vitam Nutr Res. 1984;54(4):343-7
6151942
JAMA. 1997 May 28;277(20):1624-32
9168293
N Engl J Med. 2000 Jan 20;342(3):154-60
10639540
J Hypertens. 2000 Apr;18(4):411-5
10779091
Int J Vitam Nutr Res. 1992;62(3):252-5
1473908
Circulation. 1996 Mar 15;93(6):1107-13
8653830
J Hum Hypertens. 1997 Jun;11(6):343-50
9249227
Circ Res. 1998 Nov 2;83(9):916-22
9797340
Hypertension. 1995 Mar;25(3):305-13
7875754
Hypertension. 2002 Dec;40(6):804-9
12468561
Circulation. 1998 Jun 9;97(22):2222-9
9631871
Lancet. 1990 Mar 31;335(8692):765-74
1969518
J Hypertens. 1990 Dec;8(12):1071-5
1962794
J Hypertens. 1998 Sep;16(9):1267-71
9746113
Am J Ther. 2002 Jul-Aug;9(4):289-93
12115017
Am J Physiol Heart Circ Physiol. 2001 Feb;280(2):H528-34
11158948
Circulation. 1999 Jun 29;99(25):3234-40
10385496
Ann N Y Acad Sci. 2004 Dec;1031:204-13
15753146
Gerontology. 1994;40(5):268-72
7959083
Ann Intern Med. 1996 May 1;124(9):825-31
8610952
Lancet. 1999 Aug 7;354(9177):447-55
10465168
Clin Sci (Lond). 2002 Oct;103(4):339-44
12241530
Ann Nutr Metab. 1995;39(4):217-23
8546437
J Biol Chem. 2000 Jun 9;275(23):17399-406
10749876
Cell Mol Biol Lett. 2004;9(4A):635-41
15647786
J Hypertens. 1996 Apr;14(4):503-8
8761901
J Biol Chem. 2001 Jan 5;276(1):40-7
11022034